Vantage Investment Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-13
Closed -$3K 813
2015
Q4
$3K Hold
13
﹤0.01% 663
2015
Q3
$2K Hold
13
﹤0.01% 700
2015
Q2
$5K Hold
13
﹤0.01% 598
2015
Q1
$6K Hold
13
﹤0.01% 670
2014
Q4
$4K Hold
13
﹤0.01% 632
2014
Q3
$3K Hold
13
﹤0.01% 620
2014
Q2
$3K Buy
13
+9
+225% +$2.08K ﹤0.01% 614
2014
Q1
$1K Sell
4
-29
-88% -$7.25K ﹤0.01% 628
2013
Q4
$12K Buy
+33
New +$12K 0.01% 388